Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.

@article{Sepulveda2017MolecularBF,
  title={Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.},
  author={Antonia Rogado Sepulveda and Stanley R. Hamilton and Carmen Joseph Allegra and Wayne W. Grody and Allison M. Cushman-Vokoun and William K. Funkhouser and Scott Kopetz and Christopher Hanyoung Lieu and Noralane M. Lindor and Bruce Daniel Minsky and Federico A. Monzon and Daniel J. Sargent and Veena Singh and Joseph Willis and Jennifer Clark and Carol Colasacco and Rob Rumble and Robyn L Temple-Smolkin and Christina B. Ventura and Jan A Nowak},
  journal={The Journal of molecular diagnostics : JMD},
  year={2017},
  volume={19 2},
  pages={187-225}
}
OBJECTIVES To develop evidence-based guideline recommendations through a systematic review of the literature to establish standard molecular biomarker testing of colorectal cancer (CRC) tissues to guide epidermal growth factor receptor (EGFR) therapies and conventional chemotherapy regimens. METHODS The American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology convened an expert panel to develop an… CONTINUE READING